SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Alpha Tau Medical Ltd. (DRTSW) News

Follow Alpha Tau Medical Ltd. (DRTSW) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol DRTSW Asset equity Sector Markets 90 days 2 Last 1.72 Updated Oct 19, 2026, 12:30 PM UTC Open live news feed Open DRTSW chart & news
L FDA approves expansion of Alpha Tau’s U.S. REGAIN trial Alpha Tau says the FDA approved an expansion of its U.S. recurrent glioblastoma REGAIN trial. New trial data will be presented at the SNO 2026 Annual Meeting. REGULATION | Oct 19, 2026, 12:30 PM UTC L DRTS DRTSW - Alpha Tau to Participate in September Investor Conferences DRTS DRTSW - Alpha Tau to Participate in September Investor Conferences EQUITY | Sep 02, 2026, 12:02 PM UTC M DRTS: Treats Glioblastoma Patient Alpha Tau successfully treats first recurrent glioblastoma patient outside of the US with Alpha DaRT at Hadassah University Medical Center in Israel EQUITY | Jun 23, 2026, 12:30 PM UTC